About J.H. (Jan) von der Thüsen, MD PhD
Bristol Myers Squibb B.V.: Validation and implementation of predictive tumour mutational burden (TMB) testing for
immunotherapy in lung cancer.
immunotherapy in lung cancer.
Principal Investigator
J.H. (Jan) von der Thüsen, MD PhD
Principal Investigator
- Department
- Pathology and Clinical Bioinformatics
